Fred Poordad
AuthID: R-00F-H8Z
1
TÃTULO: Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir plus dasabuvir +/- ribavirin in the TOPAZ-I and TOPAZ-II trials
AUTORES: Fred Poordad; Rui Sarmento E Castro; Armen Asatryan; Humberto Aguilar; Patrice Cacoub; Douglas Dieterich; Rui Marinho; Armando Carvalho; Asma Siddique; Yiran R Hu; Mariem Charafeddine; Mark Bondin; Nader Khan; Daniel Cohen; Franco Felizarta;
PUBLICAÇÃO: 2019, FONTE: International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) in JOURNAL OF HEPATOLOGY, VOLUME: 70
AUTORES: Fred Poordad; Rui Sarmento E Castro; Armen Asatryan; Humberto Aguilar; Patrice Cacoub; Douglas Dieterich; Rui Marinho; Armando Carvalho; Asma Siddique; Yiran R Hu; Mariem Charafeddine; Mark Bondin; Nader Khan; Daniel Cohen; Franco Felizarta;
PUBLICAÇÃO: 2019, FONTE: International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) in JOURNAL OF HEPATOLOGY, VOLUME: 70
INDEXADO EM: 
WOS
WOS2
TÃTULO: Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
AUTORES: Stefan Zeuzem; Ira M Jacobson; Tolga Baykal; Rui T Marinho; Fred Poordad; Marc Bourliere; Mark S Sulkowski; Heiner Wedemeyer; Edward Tam; Paul Desmond; Donald M Jensen; Adrian M Di Bisceglie; Peter Varunok; Tarek Hassanein; Junyuan Y Xiong; Tami Pilot Matias; Barbara DaSilva Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein;
PUBLICAÇÃO: 2014, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 370, NÚMERO: 17
AUTORES: Stefan Zeuzem; Ira M Jacobson; Tolga Baykal; Rui T Marinho; Fred Poordad; Marc Bourliere; Mark S Sulkowski; Heiner Wedemeyer; Edward Tam; Paul Desmond; Donald M Jensen; Adrian M Di Bisceglie; Peter Varunok; Tarek Hassanein; Junyuan Y Xiong; Tami Pilot Matias; Barbara DaSilva Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein;
PUBLICAÇÃO: 2014, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 370, NÚMERO: 17
